288. Autoimmune acquired coagulation factor deficiency Clinical trials / Disease details
Clinical trials : 206 / Drugs : 231 - (DrugBank : 28) / Drug target genes : 10 - Drug target pathways : 21
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00557908 (ClinicalTrials.gov) | June 2007 | 13/11/2007 | The Von Willebrand Disease (VWD) International Prophylaxis Study | The VWD International Prophylaxis (VIP) Study | Von Willebrand Disease | Drug: VWF/FVIII products | Skane University Hospital | Blood Center of Wisconsin;CSL Behring | Completed | N/A | N/A | All | 105 | N/A | United States;Sweden |